Sankar, Aditya http://orcid.org/0000-0002-1840-3356
Mohammad, Faizaan
Sundaramurthy, Arun Kumar http://orcid.org/0000-0003-1287-0591
Wang, Hua
Lerdrup, Mads
Tatar, Tulin http://orcid.org/0000-0003-3289-3299
Helin, Kristian http://orcid.org/0000-0003-1975-6097
Funding for this research was provided by:
Brain Tumour Charity (GN-00358)
Novo Nordisk Fonden (NNF17CC0027852)
U.S. Department of Health & Human Services | National Institutes of Health (P30 CA008748)
EC | Horizon 2020 Framework Programme (MSCA-ITN-2018-813327)
Neye Foundation
Article History
Received: 16 February 2021
Accepted: 4 May 2022
First Online: 6 June 2022
Competing interests
: K.H. is a co-founder of Dania Therapeutics ApS, a consultant for Inthera Bioscience and a scientific advisor for MetaboMed and Hannibal Innovation. All other authors have no competing interests.